Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
About Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
During the past decade, Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
2020-09-28
2025-06-27
Recruiting
750
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
2021-11-18
2026-03-06
Recruiting
690
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny"
#1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
According to Clinical.Site data, the most researched conditions in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are
"Esophageal Squamous Cell Carcinoma" (1 trials) and "Small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" in a lesser frequency.
Clinical Trials Intervention Types at Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
Most popular intervention types in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Carboplatin" (1 trials), "Etoposide" (1 trials) and "Lurbinectedin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
The vast majority of trials in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny" are
2 trials for "All" genders.
Clinical Trials Status at Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny
Currently, there are NaN active trials in "Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krakowski Szpital Specjalistyczny im. Jana Pawła II; Oddział Onkologiczny, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".